113 related articles for article (PubMed ID: 19223412)
1. Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis.
Tahara N; Imaizumi T; Virmani R; Narula J
J Nucl Med; 2009 Mar; 50(3):331-4. PubMed ID: 19223412
[TBL] [Abstract][Full Text] [Related]
2. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice.
Zhao Y; Kuge Y; Zhao S; Morita K; Inubushi M; Strauss HW; Blankenberg FG; Tamaki N
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1747-55. PubMed ID: 17437104
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging of vascular inflammation.
Tahara N; Tahara A; Honda A; Nitta Y; Kodama N; Yamagishi S; Imaizumi T
Curr Pharm Des; 2014; 20(14):2439-47. PubMed ID: 23844819
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
Tahara N; Kai H; Ishibashi M; Nakaura H; Kaida H; Baba K; Hayabuchi N; Imaizumi T
J Am Coll Cardiol; 2006 Nov; 48(9):1825-31. PubMed ID: 17084257
[TBL] [Abstract][Full Text] [Related]
6. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study.
Arauz A; Hoyos L; Zenteno M; Mendoza R; Alexanderson E
Clin Neurol Neurosurg; 2007 Jun; 109(5):409-12. PubMed ID: 17418484
[TBL] [Abstract][Full Text] [Related]
7. 18FDG PET and ultrasound echolucency in carotid artery plaques.
Graebe M; Pedersen SF; Højgaard L; Kjaer A; Sillesen H
JACC Cardiovasc Imaging; 2010 Mar; 3(3):289-95. PubMed ID: 20223427
[TBL] [Abstract][Full Text] [Related]
8. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
Figueroa AL; Subramanian SS; Cury RC; Truong QA; Gardecki JA; Tearney GJ; Hoffmann U; Brady TJ; Tawakol A
Circ Cardiovasc Imaging; 2012 Jan; 5(1):69-77. PubMed ID: 22038986
[TBL] [Abstract][Full Text] [Related]
9. Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging.
Kwee RM; Teule GJ; van Oostenbrugge RJ; Mess WH; Prins MH; van der Geest RJ; Ter Berg JW; Franke CL; Korten AG; Meems BJ; Hofman PA; van Engelshoven JM; Wildberger JE; Kooi ME
Stroke; 2009 Dec; 40(12):3718-24. PubMed ID: 19875738
[TBL] [Abstract][Full Text] [Related]
10. Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography.
Kai H
Geriatr Gerontol Int; 2010 Jan; 10(1):1-8. PubMed ID: 20102376
[TBL] [Abstract][Full Text] [Related]
11. (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation.
Chen W; Dilsizian V
Curr Cardiol Rep; 2010 Mar; 12(2):179-84. PubMed ID: 20425174
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina.
Rogers IS; Nasir K; Figueroa AL; Cury RC; Hoffmann U; Vermylen DA; Brady TJ; Tawakol A
JACC Cardiovasc Imaging; 2010 Apr; 3(4):388-97. PubMed ID: 20394901
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET).
Graebe M; Pedersen SF; Borgwardt L; Højgaard L; Sillesen H; Kjaer A
Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):714-21. PubMed ID: 19112034
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of inflammation in atherosclerosis.
Tarkin JM; Joshi FR; Rudd JH
Nat Rev Cardiol; 2014 Aug; 11(8):443-57. PubMed ID: 24913061
[TBL] [Abstract][Full Text] [Related]
15. Imaging apoptosis for detecting plaque instability: rendering death a brighter facade.
Corsten MF; Reutelingsperger CP; Hofstra L
Curr Opin Biotechnol; 2007 Feb; 18(1):83-9. PubMed ID: 17275277
[TBL] [Abstract][Full Text] [Related]
16. Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy.
Ozaki Y; Okumura M; Ismail TF; Motoyama S; Naruse H; Hattori K; Kawai H; Sarai M; Takagi Y; Ishii J; Anno H; Virmani R; Serruys PW; Narula J
Eur Heart J; 2011 Nov; 32(22):2814-23. PubMed ID: 21719455
[TBL] [Abstract][Full Text] [Related]
17. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.
Laufer EM; Winkens HM; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L
Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):26-34. PubMed ID: 19182725
[TBL] [Abstract][Full Text] [Related]
18. Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging.
Sarai M; Hartung D; Petrov A; Zhou J; Narula N; Hofstra L; Kolodgie F; Isobe S; Fujimoto S; Vanderheyden JL; Virmani R; Reutelingsperger C; Wong ND; Gupta S; Narula J
J Am Coll Cardiol; 2007 Dec; 50(24):2305-12. PubMed ID: 18068039
[TBL] [Abstract][Full Text] [Related]
19. Imaging of atherosclerosis.
Owen DR; Lindsay AC; Choudhury RP; Fayad ZA
Annu Rev Med; 2011; 62():25-40. PubMed ID: 21226610
[TBL] [Abstract][Full Text] [Related]
20. F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.
Kang WJ
Korean J Radiol; 2015; 16(6):1257-61. PubMed ID: 26576114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
